Trial Profile
Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Lazuvapagon (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 12 Apr 2018 Status changed from recruiting to completed.
- 20 Apr 2017 New trial record